63279-58-3

Basic information

• Product Name: 1-Bromo-4-iodonaphthalene
• Synonyms: 1-Bromo-4-iodonaphthalene;1-Iodo-4-bromonaphthalene;-BroMo-4-iodonaphthalene;1,4-BIN;1-Bromo-4-iodophthalene;1-Bromo-4-iodonaphthalene, 98% solid
• CAS NO: 63279-58-3
• Molecular Formula: C₁₀H₆BrI
• Molecular Weight: 332.96311
• Mol File: 63279-58-3.mol
• Article Data: 5

Chemical Properties

• Melting Point: 88-89℃
• Boiling Point: 357.3±15.0 °C(Predicted)
• Appearance: /Solid
• Density: 2.057
• Storage Temp.: 2-8°C(protect from light)
• Water Solubility: Slightly soluble in water. (3.6 g/L) (25°C)
• Sensitive: Light Sensitive
• CAS DataBase Reference: 1-Bromo-4-iodonaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-4-iodonaphthalene(63279-58-3)
• EPA Substance Registry System: 1-Bromo-4-iodonaphthalene(63279-58-3)

Safety Data

• Hazardous Substances Data: 63279-58-3(Hazardous Substances Data)

Upstream product

• 162109-21-9 4-iodo-naphthalene-1-sulfonic acid 
• 7726-95-6 bromine 
• 83-53-4 1,4-dibromonaphthalene 
• 2298-07-9 4-Bromo-1-naphthylamine 

Downstream Products

• 59951-65-4 1-bromo-4-phenylnaphthalene 
• 1312609-72-5 1-bromo-4-(4-methoxyphenyl)naphthalene 
• 1312609-73-6 4-(1-bromonaphthalen-4-yl)phenol 
• 1296203-34-3 1-bromo-4-(4-n-propylphenylethynyl)naphthalene 
• 227314-47-8 4-bromo-1-(N,N-diphenylamino)naphthalene 
• 6627-78-7 1-bromo-4-methylnaphthalene 

Relevant articles and documents

Synthesis of extended ethynylnaphthalene-based ruthenium(II) 2,2′:6′,2″-terpyridine complexes

A 'synthesis-at-metal' approach is used for the preparation of a new class of luminescent metal complexes having closely-spaced triplet excited states. A 'synthesis-at-metal' approach is described for the preparation of extended ethynylnaphthalene-based ruthenium(II) 2,2′:6′,2″-terpyridine complexes.

COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND THE USE THEREOF FOR HIGH-FREQUENCY COMPONENTS

The present invention relates to compounds of the formula I where one or more of the radicals A1-5 denote a 1,4-naphthylene or 1,4- or 9,10-anthracenylene radical, and the other parameters are as defined in Claim 1. The invention additionally includes liquid-crystalline media which comprise the title compounds, and components for high-frequency technology which comprise these media, in particular phase shifters and microwave array antennae.

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.